Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 158.2 | 90.3 | 68.8 | 56.3 |
| Revenue growth | 75.3% | 31.2% | 22.1% | |
| Cost of goods sold | 30.2 | 17.8 | 12.4 | 10.6 |
| Gross profit | 128.0 | 72.5 | 56.4 | 45.8 |
| Gross margin | 80.9% | 80.3% | 82.0% | 81.2% |
| Sales and marketing | 50.3 | 33.1 | 28.8 | 29.4 |
| Research and development | | 24.6 | 18.3 | 14.8 |
| General and administrative | 39.1 | 20.7 | 8.2 | 7.6 |
| EBIT | -29.7 | -5.8 | 1.1 | -6.0 |
| EBIT margin | -18.8% | -6.5% | 1.6% | -10.7% |
| Pre-tax income | -16.4 | -10.2 | 0.4 | -6.4 |
| Income taxes | 2.0 | 1.2 | 1.2 | 0.9 |
| Tax rate | | | 309.3% | |
| Net income | -18.4 | -88.5 | -8.1 | -9.3 |
| Net margin | -11.6% | -98.1% | -11.8% | -16.6% |
| |
| Diluted EPS | | ($3.31) | ($0.51) | ($0.59) |
| Shares outstanding (diluted) | | 26.7 | 16.0 | 15.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|